214 related articles for article (PubMed ID: 20566715)
21. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
[TBL] [Abstract][Full Text] [Related]
22. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
[TBL] [Abstract][Full Text] [Related]
23. Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis.
Penzotti JE; Nepom GT; Lybrand TP
Arthritis Rheum; 1997 Jul; 40(7):1316-26. PubMed ID: 9214433
[TBL] [Abstract][Full Text] [Related]
24. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
Sheehy MJ
Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
[TBL] [Abstract][Full Text] [Related]
25. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
Brawley JV; Concannon P
J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
[TBL] [Abstract][Full Text] [Related]
26. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
[TBL] [Abstract][Full Text] [Related]
27. The shaping of T cell receptor recognition by self-tolerance.
Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
[TBL] [Abstract][Full Text] [Related]
28. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.
Gao GF; Willcox BE; Wyer JR; Boulter JM; O'Callaghan CA; Maenaka K; Stuart DI; Jones EY; Van Der Merwe PA; Bell JI; Jakobsen BK
J Biol Chem; 2000 May; 275(20):15232-8. PubMed ID: 10809759
[TBL] [Abstract][Full Text] [Related]
29. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors.
Sooda A; Rwandamuriye F; Wanjalla CN; Jing L; Koelle DM; Peters B; Leary S; Chopra A; Calderwood MA; Mallal SA; Pavlos R; Watson M; Phillips EJ; Redwood AJ
Commun Biol; 2022 Feb; 5(1):133. PubMed ID: 35173258
[TBL] [Abstract][Full Text] [Related]
30. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
[TBL] [Abstract][Full Text] [Related]
31. Determinants of gliadin-specific T cell selection in celiac disease.
Petersen J; van Bergen J; Loh KL; Kooy-Winkelaar Y; Beringer DX; Thompson A; Bakker SF; Mulder CJ; Ladell K; McLaren JE; Price DA; Rossjohn J; Reid HH; Koning F
J Immunol; 2015 Jun; 194(12):6112-22. PubMed ID: 25948817
[TBL] [Abstract][Full Text] [Related]
32. The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.
Abels WC; Manandhar T; Kunze-Schumacher H; Blasczyk R; Bade-Döding C
Immunogenetics; 2018 Nov; 70(10):639-646. PubMed ID: 30128813
[TBL] [Abstract][Full Text] [Related]
33. Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity.
DeWitt WS; Smith A; Schoch G; Hansen JA; Matsen FA; Bradley P
Elife; 2018 Aug; 7():. PubMed ID: 30152754
[TBL] [Abstract][Full Text] [Related]
34. Cis-trans isomerization of the Epstein-Barr virus determinant peptide EENLLDFVRF after the DM1 TCR recognition of the HLA-B*4405/peptide complex.
Stavrakoudis A
FEBS Lett; 2011 Feb; 585(3):485-91. PubMed ID: 21167154
[TBL] [Abstract][Full Text] [Related]
35. Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.
Zhao X; Sankaran S; Yap J; Too CT; Ho ZZ; Dolton G; Legut M; Ren EC; Sewell AK; Bertoletti A; MacAry PA; Brzostek J; Gascoigne NRJ
Nat Commun; 2018 Jul; 9(1):2716. PubMed ID: 30006605
[TBL] [Abstract][Full Text] [Related]
36. T cell allorecognition via molecular mimicry.
Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
[TBL] [Abstract][Full Text] [Related]
37. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules.
Tomiyama H; Yamada N; Komatsu H; Hirayama K; Takiguchi M
Eur J Immunol; 2000 Sep; 30(9):2521-30. PubMed ID: 11009085
[TBL] [Abstract][Full Text] [Related]
38. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
39. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
40. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
Lanzarotti E; Marcatili P; Nielsen M
Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
